10703776

Source:http://linkedlifedata.com/resource/pubmed/id/10703776

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0032143, umls-concept:C0038454, umls-concept:C0087111, umls-concept:C0348016, umls-concept:C0751956, umls-concept:C1442989, umls-concept:C1555029, umls-concept:C1825825, umls-concept:C2603343
pubmed:issue	9
pubmed:dateCreated	2000-3-9
pubmed:abstractText	Tissue-type plasminogen activator (tPA) is the only therapy for acute ischemic stroke approved by the Food and Drug Administration.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10703776-10703782
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7501160
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activators, http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0098-7484
pubmed:author	pubmed-author:AlbersG WGW, pubmed-author:BatesV EVE, pubmed-author:BellRR, pubmed-author:ClarkW MWM, pubmed-author:HamiltonS ASA, pubmed-author:VerroPP
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	283
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1145-50
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:10703776-Adult, pubmed-meshheading:10703776-Aged, pubmed-meshheading:10703776-Aged, 80 and over, pubmed-meshheading:10703776-Cerebral Hemorrhage, pubmed-meshheading:10703776-Female, pubmed-meshheading:10703776-Humans, pubmed-meshheading:10703776-Infusions, Intravenous, pubmed-meshheading:10703776-Male, pubmed-meshheading:10703776-Middle Aged, pubmed-meshheading:10703776-Multivariate Analysis, pubmed-meshheading:10703776-Plasminogen Activators, pubmed-meshheading:10703776-Prospective Studies, pubmed-meshheading:10703776-Severity of Illness Index, pubmed-meshheading:10703776-Stroke, pubmed-meshheading:10703776-Survival Analysis, pubmed-meshheading:10703776-Thrombolytic Therapy, pubmed-meshheading:10703776-Time Factors, pubmed-meshheading:10703776-Tissue Plasminogen Activator, pubmed-meshheading:10703776-Treatment Outcome
pubmed:year	2000
pubmed:articleTitle	Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
pubmed:affiliation	Stanford Stroke Center, Stanford University Medical Center, Palo Alto, Calif 94304-1705, USA. albers@leland.stanford.edu
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase IV